pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
ECC-0509
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Eccogene (Shanghai) Co Ltd
Phase 2
ECC-4703
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Eccogene (Shanghai) Co Ltd
Phase 3
ECUR-506
Ornithine-Transcarbamylase Deficiency
iECURE Inc
Phase 2
← prev
page 80 of 231
next →
131
Pain
89
Neurology
1
EDV-2209
Subarachnoid Hemorrhage
Edvince AB
Phase 2
EEDVD-682
Pancreatic Ductal Adenocarcinoma
EnGeneIC Ltd
Phase 2
EF-001
Anaplastic Astrocytoma
Everfront Biotech Inc
Preclinical
EF-005
Alzheimer's Disease
Everfront Biotech Inc
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
no indication
CIPLA
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
no indication
LAURUS
Phase 1
EG-001
Idiopathic Interstitial Pneumonia (IIP)
Shenzhen Evergreen Therapeutics Co Ltd
Phase 2
EG-007
Endometrial Cancer
Shenzhen Evergreen Therapeutics Co Ltd
Phase 1
EG-009
Coronavirus Disease 2019 (COVID-19) Associated Cytokine R…
Shenzhen Evergreen Therapeutics Co Ltd
Preclinical
EG-102
Focal Segmental Glomerulosclerosis (FSGS)
Shenzhen Evergreen Therapeutics Co Ltd
Phase 2
EG-110A
Neurogenic Bladder Dysfunction
EG 427
Preclinical
EG-201
Wet (Neovascular / Exudative) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
Phase 1
EG-301
Dry (Atrophic) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
Preclinical
EG-401
Diabetic Retinopathy
Shenzhen Evergreen Therapeutics Co Ltd
Preclinical
EG-402
Retinopathy Of Prematurity
Shenzhen Evergreen Therapeutics Co Ltd
Phase 2
EG-501
Cognitive Impairment
Shenzhen Evergreen Therapeutics Co Ltd
Preclinical
EG-Mirotin
Diabetic Retinopathy
EyeGene Inc
Phase 2
EGT-101
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
Preclinical
EGT-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
Preclinical
EGT-301
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Esteve Pharmaceuticals SA
Phase 2
EH-301
Amyotrophic Lateral Sclerosis
Elysium Health Inc
Preclinical
EIR-0205
Dry (Atrophic) Macular Degeneration
EIR Biopharma Inc
Preclinical
EIR-1003
Neovascular Glaucoma
EIR Biopharma Inc
Phase 2
EIS-12656
Breast Cancer
Eisbach Bio GmbH
Preclinical
EKZ-102
Parkinson's Disease
Eikonizo Therapeutics Inc
Preclinical
EL-100
Critical Limb Ischemia
Elphis Cell Therapeutics Co Ltd
Phase 1
EL-22
Obesity
Northstrive Biosciences Inc
